000 03603nam a22005655i 4500
001 978-981-13-2402-4
003 DE-He213
005 20220801214931.0
007 cr nn 008mamaa
008 180914s2019 si | s |||| 0|eng d
020 _a9789811324024
_9978-981-13-2402-4
024 7 _a10.1007/978-981-13-2402-4
_2doi
050 4 _aR856-857
072 7 _aMQW
_2bicssc
072 7 _aTEC059000
_2bisacsh
072 7 _aMQW
_2thema
082 0 4 _a610.28
_223
100 1 _aHo, Yvonne.
_eauthor.
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_941349
245 1 0 _aPatient-Specific Controller for an Implantable Artificial Pancreas
_h[electronic resource] /
_cby Yvonne Ho.
250 _a1st ed. 2019.
264 1 _aSingapore :
_bSpringer Nature Singapore :
_bImprint: Springer,
_c2019.
300 _aXXII, 84 p. 29 illus., 19 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aSpringer Theses, Recognizing Outstanding Ph.D. Research,
_x2190-5061
505 0 _aIntroduction -- Glucose Metabolism and Diabetes -- Literature Review -- Design of an Implantable Artificial Pancreas -- Model Predictive Controller using Interior Point and Ant Algorithm -- In Vivo Experiment of the Implantable Artificial Pancreas -- Parameter Estimation for Nonlinear Mathematical Model -- Conclusion and Future Work.
520 _aThe thesis focuses on the control of blood glucose devices and design of implantable devices, and offers valuable insights on diabetes mellitus and related physiology and treatments. Diabetes mellitus is a widespread chronic disease in the modern world that affects millions of people around the globe. In Singapore, one in ten of the population has diabetes, and the severity of the problem has prompted the country’s prime minister to talk about the disease at the National Day Rally in 2017. Designing an artificial pancreas that can provide effective blood glucose control for individuals with diabetes is one of the most challenging engineering problems. The author reports on research into the development of an implantable artificial pancreas that can regulate blood glucose levels by delivering appropriate dosages of insulin when necessary. By sensing blood glucose and injecting insulin directly into the vein, the implantable device aims to remove delays that occur with subcutaneous blood glucose sensing and insulin delivery. Preliminary in-vitro and in-vivo experimental results suggest that the implantable device for blood glucose control could be a clinically viable alternative to pancreas transplant.
650 0 _aBiomedical engineering.
_93292
650 0 _aBiotechnology.
_97533
650 0 _aDiseases.
_941350
650 0 _aControl engineering.
_931970
650 1 4 _aBiomedical Engineering and Bioengineering.
_931842
650 2 4 _aBiotechnology.
_97533
650 2 4 _aDiseases.
_941350
650 2 4 _aControl and Systems Theory.
_931972
710 2 _aSpringerLink (Online service)
_941351
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9789811324017
776 0 8 _iPrinted edition:
_z9789811324031
776 0 8 _iPrinted edition:
_z9789811347702
830 0 _aSpringer Theses, Recognizing Outstanding Ph.D. Research,
_x2190-5061
_941352
856 4 0 _uhttps://doi.org/10.1007/978-981-13-2402-4
912 _aZDB-2-ENG
912 _aZDB-2-SXE
942 _cEBK
999 _c76919
_d76919